Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mossad, S.B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mossad, S.B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2003; 96: 35-43
© 2003 Association of Physicians

Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults

S.B. Mossad

From the Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, USA

Received 27 September 2002 Accepted for publication 25 October 2002.

Background: Previous studies suggest that zinc salts may be effective in treating the common cold. Since rhinovirus infections occur primarily in the nasal cavity, an attempt to arrest the infection at the portal of entry seems logical.

Aim: To assess the ability of zinc nasal gel to shorten the duration and reduce the severity of the common cold in healthy adults.

Study design: Randomized, double blind, placebo-controlled study.

Methods:  Of 1087 patients screened by telephone, 80 patients were enrolled, all presenting within 24–48 h of the onset of illness. They received one dose per nostril of a nasal gel spray containing either 33 mmol/l zincum gluconicum, or an identical placebo four times daily until their symptoms resolved, for a maximum of 10 days.

Results: Median duration of cold symptoms in the zinc group was significantly shorter than in the placebo group (median [IQR] 4.3 days [2.5–5.5] vs. 6 days [5–8.5], p=0.002). Nasal drainage, nasal congestion, hoarseness, and sore throat were the symptoms most affected. Significant reduction of total symptom scores started from the second day of the study. Adverse effects (mainly nasal stinging) were similar in both groups.

Discussion: Zincum gluconicum nasal gel shortens duration and reduces symptom severity of the common cold in healthy adults, when started within 24–48 h of the onset of illness.

Address correspondence to Dr S.B. Mossad, Department of Infections Diseases, S-32, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA. e-mail: mossads{at}ccf.org


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
W. G. Nichols, A. J. Peck Campbell, and M. Boeckh
Respiratory Viruses Other than Influenza Virus: Impact and Therapeutic Advances
Clin. Microbiol. Rev., April 1, 2008; 21(2): 274 - 290.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Zsembery, J. A. Fortenberry, L. Liang, Z. Bebok, T. A. Tucker, A. T. Boyce, G. M. Braunstein, E. Welty, P. D. Bell, E. J. Sorscher, et al.
Extracellular Zinc and ATP Restore Chloride Secretion across Cystic Fibrosis Airway Epithelia by Triggering Calcium Entry
J. Biol. Chem., March 12, 2004; 279(11): 10720 - 10729.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.